Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: CANNABINOIDS, . Treffer: 29

2020

Kienzl, M; Storr, M; Schicho, R Cannabinoids and Opioids in the Treatment of Inflammatory Bowel Diseases.
Clin Transl Gastroenterol. 2020; 11(1):e00120-e00120 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Likar, R; Köstenberger, M; Nahler, G [Cannabidiol in cancer treatment].
Schmerz. 2020; 34(2):117-122
Web of Science PubMed FullText FullText_MUG

 

2019

Farzi, A; Hassan, AM; Zenz, G; Holzer, P Diabesity and mood disorders: Multiple links through the microbiota-gut-brain axis.
Mol Aspects Med. 2019; 66(2):80-93 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Grill, M; Högenauer, C; Blesl, A; Haybaeck, J; Golob-Schwarzl, N; Ferreirós, N; Thomas, D; Gurke, R; Trötzmüller, M; Köfeler, HC; Gallé, B; Schicho, R Members of the endocannabinoid system are distinctly regulated in inflammatory bowel disease and colorectal cancer.
Sci Rep. 2019; 9(1): 2358-2358. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Likar, R; Koestenberger, M; Stultschnig, M; Nahler, G Concomitant Treatment of Malignant Brain Tumours With CBD - A Case Series and Review of the Literature.
Anticancer Res. 2019; 39(10):5797-5801
Web of Science PubMed FullText FullText_MUG

 

2018

Bondarenko, AI; Panasiuk, O; Drachuk, K; Montecucco, F; Brandt, KJ; Mach, F The quest for endothelial atypical cannabinoid receptor: BKCa channels act as cellular sensors for cannabinoids in in vitro and in situ endothelial cells.
Vascul Pharmacol. 2018; 102(4):44-55 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Klivinyi, C; Bornemann-Cimenti, H Pain medication and long QT syndrome.
Korean J Pain. 2018; 31(1): 3-9. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2017

Hasenoehrl, C; Storr, M; Schicho, R Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?
Expert Rev Gastroenterol Hepatol. 2017; 11(4):329-337 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Likar, R; Pipam, W; Kostenberger, M; Neuwersch, S Cannabinoids in Clinical Practice Dronabinol for the Treatment of Therapy-Resistant Nausea and Vomiting of Cancer Patients in Palliative Care
Z PALLIATMEDIZIN. 2017; 18(5): 249-254.
Web of Science FullText FullText_MUG

 

2016

Hasenoehrl, C; Taschler, U; Storr, M; Schicho, R The gastrointestinal tract - a central organ of cannabinoid signaling in health and disease.
Neurogastroenterol Motil. 2016; 28(12):1765-1780 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Mörkl, S; Blesl, C; Wurm, WE; Tmava, A [Acute Psychosis after Consumption of Synthetic Cannabinoids].
Fortschr Neurol Psychiatr. 2016; 84(3):150-154 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2015

Imperatore, R; Morello, G; Luongo, L; Taschler, U; Romano, R; De Gregorio, D; Belardo, C; Maione, S; Di Marzo, V; Cristino, L Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB₁R signaling and anxiety-like behavior.
J Neurochem. 2015; 135(4):799-813 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Izzo, AA; Muccioli, GG; Ruggieri, MR; Schicho, R Endocannabinoids and the Digestive Tract and Bladder in Health and Disease.
Handb Exp Pharmacol. 2015; 231(10):423-447
PubMed FullText FullText_MUG

 

Kremshofer, J; Siwetz, M; Berghold, VM; Lang, I; Huppertz, B; Gauster, M A role for GPR55 in human placental venous endothelial cells.
Histochem Cell Biol. 2015; 144(1):49-58 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Navia-Paldanius, D; Aaltonen, N; Lehtonen, M; Savinainen, JR; Taschler, U; Radner, FP; Zimmermann, R; Laitinen, JT Increased tonic cannabinoid CB1R activity and brain region-specific desensitization of CB1R Gi/o signaling axis in mice with global genetic knockout of monoacylglycerol lipase.
Eur J Pharm Sci. 2015; 77(7):180-188
Web of Science PubMed FullText FullText_MUG

 

Stančić, A; Jandl, K; Hasenöhrl, C; Reichmann, F; Marsche, G; Schuligoi, R; Heinemann, A; Storr, M; Schicho, R The GPR55 antagonist CID16020046 protects against intestinal inflammation.
Neurogastroenterol Motil. 2015; 27(10):1432-1445 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2014

Bondarenko, AI Endothelial atypical cannabinoid receptor: do we have enough evidence?
Br J Pharmacol. 2014; 171(24):5573-5588 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Schicho, R; Storr, M Cannabis finds its way into treatment of Crohn's disease.
Pharmacology. 2014; 93(1-2):1-3 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2013

Deak, AT; Groschner, LN; Alam, MR; Seles, E; Bondarenko, AI; Graier, WF; Malli, R The endocannabinoid N-arachidonoyl glycine (NAGly) inhibits store-operated Ca2+ entry by preventing STIM1-Orai1 interaction.
J Cell Sci. 2013; 126(Pt 4):879-888 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kargl, J; Brown, AJ; Andersen, L; Dorn, G; Schicho, R; Waldhoer, M; Heinemann, A A selective antagonist reveals a potential role of G protein-coupled receptor 55 in platelet and endothelial cell function.
J Pharmacol Exp Ther. 2013; 346(1):54-66 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kargl, J; Haybaeck, J; Stančić, A; Andersen, L; Marsche, G; Heinemann, A; Schicho, R O-1602, an atypical cannabinoid, inhibits tumor growth in colitis-associated colon cancer through multiple mechanisms.
J Mol Med (Berl). 2013; 91(4):449-458 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2012

Schicho, R; Storr, M A potential role for GPR55 in gastrointestinal functions.
Curr Opin Pharmacol. 2012; 12(6):653-658 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Schicho, R; Storr, M Topical and systemic cannabidiol improves trinitrobenzene sulfonic acid colitis in mice.
Pharmacology. 2012; 89(3-4):149-155 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2011

Balenga, NA; Aflaki, E; Kargl, J; Platzer, W; Schröder, R; Blättermann, S; Kostenis, E; Brown, AJ; Heinemann, A; Waldhoer, M GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils.
Cell Res. 2011; 21(10):1452-1469 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

Schicho, R; Bashashati, M; Bawa, M; McHugh, D; Saur, D; Hu, HM; Zimmer, A; Lutz, B; Mackie, K; Bradshaw, HB; McCafferty, DM; Sharkey, KA; Storr, M The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment.
Inflamm Bowel Dis. 2011; 17(8):1651-1664 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Schicho, R; Storr, M Alternative targets within the endocannabinoid system for future treatment of gastrointestinal diseases.
CAN J GASTROENTEROL. 2011; 25(7): 377-383. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2009

Henstridge, CM; Balenga, NA; Ford, LA; Ross, RA; Waldhoer, M; Irving, AJ The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation.
FASEB J. 2009; 23(1): 183-193. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2007

Martini, L; Waldhoer, M; Pusch, M; Kharazia, V; Fong, J; Lee, JH; Freissmuth, C; Whistler, JL Ligand-induced down-regulation of the cannabinoid 1 receptor is mediated by the G-protein-coupled receptor-associated sorting protein GASP1.
FASEB J. 2007; 21(3): 802-811. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

1999

Mombouli, JV; Schaeffer, G; Holzmann, S; Kostner, GM; Graier, WF Anandamide-induced mobilization of cytosolic Ca2+ in endothelial cells.
Br J Pharmacol. 1999; 126(7):1593-1600 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

© Med Uni Graz Impressum